What Is Free Testosterone and Why Does It Matter?

Free testosterone is the small fraction of testosterone in your blood that is not attached to any protein, making it immediately available to enter cells and do its job. In most people, only about 1% to 4% of circulating testosterone floats around unbound.¹ The rest is hitching a ride on carrier proteins. That distinction between total and free testosterone turns out to be clinically meaningful, because two people with identical total testosterone levels can have very different amounts of the hormone actually reaching their tissues.

How Testosterone Travels Through the Blood

Testosterone does not simply dissolve in your bloodstream and drift toward target tissues. The vast majority of it circulates bound to proteins. The tightest grip comes from sex hormone-binding globulin (SHBG), a protein made by the liver that holds testosterone firmly enough that the hormone cannot cross into cells while attached. A looser hold comes from albumin, the most abundant protein in blood. Because albumin binds testosterone weakly, the hormone can detach from it relatively easily as blood passes through tissue capillaries. The remaining sliver, the truly free fraction, is already unbound and ready to diffuse into cells on its own.²

After you strip away both SHBG and albumin experimentally, a small additional portion of testosterone still appears to be attached to other plasma proteins, roughly 11% in one measurement study.³ So the picture is not perfectly neat, but the practical breakdown that clinicians care about is three-tiered: tightly bound to SHBG, loosely bound to albumin, and free.

The Free Hormone Hypothesis

The idea that free hormones are the ones that actually matter biologically has been around for decades and is called the free hormone hypothesis. In its simplest form, the theory says that only the unbound fraction of a hormone can leave the bloodstream, enter target cells, and trigger a response. The albumin-bound fraction is sometimes lumped in with free testosterone under the term “bioavailable testosterone,” because albumin releases its cargo so easily that the hormone becomes functionally available as blood moves through tissues.⁴

The hypothesis is not without controversy. Some research has shown that certain cells can actually pull in the entire SHBG-testosterone complex through receptor-mediated endocytosis, a process where the cell engulfs the whole carrier-plus-hormone package. Animal studies found that knocking out megalin, a receptor involved in this uptake pathway, caused resistance to sex steroid hormones, suggesting that at least some tissues rely on more than just passive diffusion of free hormone.⁵ Still, the weight of clinical evidence supports the idea that free testosterone levels track more closely with symptoms and outcomes than total testosterone alone does, even if the underlying biology is more complicated than pure diffusion.⁴

When Total Testosterone Looks Fine but Free Testosterone Does Not

This is the scenario that makes free testosterone clinically relevant for a lot of men, especially as they get older. SHBG levels tend to rise with age. When more SHBG is circulating, more testosterone gets locked up on that carrier protein, leaving less of it free. A blood test might show a total testosterone reading that falls within the normal range, but if SHBG is high enough, the free fraction can be genuinely low.

A large study of over 3,000 men found that 277 men had normal total testosterone but low calculated free testosterone. These men were older and in poorer health compared to those whose free testosterone was also normal. They reported more sexual symptoms and physical symptoms, had lower hemoglobin, and showed worse bone ultrasound parameters.⁶ In other words, their bodies were behaving as though testosterone was low, even though the standard test said otherwise. Research on age-related SHBG increases confirms that normal total testosterone does not reliably rule out androgen deficiency in older men, and age was the strongest independent predictor of a mismatch between total and free testosterone results.⁷

That said, the picture is not completely one-sided. At least one study of men with near-normal total testosterone found that hypogonadal symptom severity did not differ between those with low versus normal free testosterone levels.⁸ Symptoms of low testosterone are notoriously nonspecific. Fatigue, low libido, and poor concentration can have a dozen other explanations. So while free testosterone adds a useful diagnostic layer, it is not a perfect decoder ring for symptoms.

What Pushes SHBG Up or Down

Because SHBG is the main gatekeeper between total and free testosterone, understanding what drives it helps explain why free testosterone varies so much from person to person. SHBG is produced in the liver, and its levels respond to a range of metabolic signals.

Aging: SHBG rises steadily as men get older, which is a major reason free testosterone falls faster than total testosterone with age.
Thyroid hormones: Hyperthyroidism pushes SHBG up, while hypothyroidism brings it down. In patients treated for thyroid disorders, SHBG moves predictably in the opposite direction of treatment: antithyroid drugs lower it, and thyroid hormone replacement raises it.⁹ The mechanism involves thyroid hormones stimulating SHBG production in liver cells.¹⁰
Insulin resistance and obesity: Low SHBG is associated with insulin resistance. Excess body fat tends to suppress SHBG, which can make free testosterone look deceptively normal even when total testosterone is dropping.¹¹
Medications and substances: Various drugs, including certain anticonvulsants, and even alcohol consumption influence SHBG concentrations.¹²

The practical upshot is that a single total testosterone number, taken in isolation, can be misleading in anyone whose SHBG is abnormally high or low. A man with untreated hyperthyroidism might have a fine total testosterone level while his free testosterone is being soaked up by elevated SHBG. Conversely, someone with significant insulin resistance might have suppressed SHBG, making free testosterone appear adequate even as the whole hormonal system is under strain.

How Free Testosterone Is Measured

This is where things get technically messy, and it matters because the method used to measure free testosterone can change the number you get by a meaningful amount. The gold standard is equilibrium dialysis, a lab technique that physically separates the free fraction from bound testosterone. It is accurate but slow, expensive, and not widely available outside of research settings or specialized labs.

Most clinical settings rely on calculated free testosterone instead. The most common formula, often called the Vermeulen equation, takes your total testosterone, SHBG, and albumin levels and estimates the free fraction mathematically. This calculated value generally correlates well with equilibrium dialysis, but it consistently overestimates the actual free testosterone, in one comparison by a mean of about 34%.¹³ The overestimation does not necessarily invalidate the calculation for clinical purposes, because the reference ranges used to interpret calculated free testosterone are calibrated to account for the method. But it does mean you cannot swap a calculated value and a dialysis value and treat them as interchangeable.

One type of test to actively avoid is the analog-based free testosterone immunoassay, a direct assay that used to be common. Studies have shown that this test does not actually measure free testosterone at all. Its results tracked with total testosterone and SHBG concentrations rather than with the actual free fraction measured by dialysis. When total testosterone was held constant and free testosterone varied, the analog assay failed to detect the change.¹⁴ Most major guidelines now recommend against using analog assays, but some labs still offer them.

A newer approach using direct immunoluminometric methods has shown good agreement with the Vermeulen calculation overall, though there may be some proportional bias in women specifically.¹⁵ If your doctor orders a free testosterone test, it is worth knowing which method the lab uses. A calculated free testosterone via the Vermeulen equation, using a reliable total testosterone assay and an accurate SHBG measurement, is a solid clinical tool. An analog assay is not.

Timing Your Blood Draw

Testosterone levels are not constant throughout the day. In younger men, levels peak in the early morning and can be 20% to 25% lower by late afternoon. This is why guidelines generally recommend drawing blood before 10 a.m.¹⁶ The drop matters: in that study, 17 men who had at least one below-normal afternoon testosterone reading turned out to have completely normal levels on every morning test, raising the risk of a false low result from poorly timed blood work.

The diurnal swing does shrink with age. By around 70, the morning-to-afternoon difference narrows to about 10%. Some clinical guidance has suggested that men 45 and older can be tested as late as early afternoon without significantly distorting results.¹⁷ However, the authors of the diurnal variation study still recommended restricting testing to morning hours for both young and older men to maintain consistency.¹⁶ If you are tracking your levels over time, the most important thing is to test at the same time each visit.

Sleep quality introduces another wrinkle. In men with severe overnight oxygen desaturation, such as those with sleep apnea, the normal testosterone peak can shift from around 6 a.m. to 10 a.m., and the degree of shift correlates with the severity of desaturation.¹⁸ Untreated sleep apnea is already associated with lower testosterone levels generally, but the disrupted timing of the peak adds another reason why early-morning testing in someone with severe apnea might not capture their actual high point.

Bone, Heart, and Brain

The clinical relevance of free testosterone extends beyond sexual symptoms. In a large study of elderly Swedish men, free testosterone was an independent predictor of bone mineral density, particularly at sites rich in cortical bone like the hip and arm. Men whose free testosterone fell below the median had roughly 1.5 times the odds of osteoporosis-related fractures and twice the odds of X-ray-verified vertebral fractures.¹⁹ Free estradiol also predicted bone density at all sites, particularly in the spine, so the hormonal picture for bone health involves both androgens and estrogens working through different bone compartments.

Low testosterone has been recognized as a risk factor for cardiovascular disease, metabolic syndrome, inflammation, and abnormal blood lipids.²⁰ Long-term testosterone therapy in men with documented deficiency appears to produce sustained weight loss, reduce fasting blood glucose, and lower cardiovascular events and mortality, with evidence also suggesting it can prevent progression from prediabetes to type 2 diabetes.²¹ These findings apply to testosterone deficiency broadly, not exclusively to isolated low free testosterone, but they reinforce why accurate assessment of androgen status matters.

On the cognitive and psychiatric side, testosterone therapy has shown benefits for depressive symptoms in men with treatment-resistant depression and for specific cognitive domains like verbal memory and visuospatial processing, particularly in older or hypogonadal men.²² These are not effects that everyone with slightly below-average testosterone would notice, but for men with genuine deficiency, the brain is one more organ that responds to adequate androgen supply.

Free Testosterone in Women

Testosterone is not just a male hormone. Women produce it too, in smaller quantities, and it plays a role in libido, energy, and bone health. The clinical application of free testosterone measurement in women is less developed than in men, partly because the concentrations are so much lower that assay precision becomes a bigger problem, and partly because reference ranges are less well established.

The one area where testosterone therapy has solid guideline support in women is hypoactive sexual desire disorder (HSDD) after menopause. Clinical practice guidelines based on comprehensive meta-analyses endorse low-dose testosterone as a treatment for HSDD in postmenopausal women, and this remains the sole evidence-based indication for testosterone therapy in women.²³ Women in this situation should have their testosterone levels monitored during treatment, and the proportional bias that one study found in direct immunoluminometric testing specifically in women is worth knowing about if that method is used.¹⁵

Genetics and Individual Variation

Not everyone’s SHBG levels are driven purely by age and metabolic health. Genetic variation plays a meaningful role. Several specific gene variants in the SHBG gene are strongly associated with circulating SHBG concentrations. Validation studies have confirmed this across independent cohorts, showing that certain variants can shift SHBG levels by roughly 20% to 25% compared to the most common genotype.²⁴

Here is the interesting part: these same variants tend to push total testosterone around in parallel with SHBG, leaving free testosterone largely unaffected. In the Tromsø Study, men carrying a particular SHBG gene variant had about 15% higher total testosterone and about 25% higher SHBG compared to men without it, but their free testosterone levels did not differ significantly.²⁵ The body appears to compensate: when SHBG rises for genetic reasons, total testosterone production adjusts upward to maintain the free fraction. This is a beautiful example of homeostatic regulation, and it underscores why free testosterone can be a more stable indicator of actual androgen status than total testosterone, which bounces around with SHBG for reasons that have nothing to do with how much hormone the body is using.

Exercise, Sleep, and Acute Testosterone Shifts

Exercise causes a short-term spike in testosterone levels, including the free fraction. During moderately prolonged endurance exercise, free testosterone increased by about 40% in one study, and the rise correlated strongly with norepinephrine levels, suggesting it is driven by sympathetic nervous system stimulation of the testes rather than by any change in SHBG binding.²⁶ Interestingly, the total testosterone and SHBG responses can vary between exercise bouts. In one study comparing two different running protocols, total testosterone and SHBG sometimes dropped together after exercise, while the non-SHBG-bound fraction (including free testosterone) consistently rose and then returned to baseline during recovery.²⁷ The body seems to have compensatory mechanisms that keep the biologically active fraction available even when total levels dip.

These acute exercise effects are short-lived and should not be confused with the chronic benefits of regular training on overall testosterone status. They do, however, illustrate why you should avoid getting blood drawn immediately after a hard workout if you want a representative testosterone reading.

What Happens to Free Testosterone During Testosterone Therapy

When men with low testosterone receive replacement therapy, free testosterone rises substantially, sometimes overshooting the normal range. In one study, men with Klinefelter syndrome who received testosterone treatment saw their free testosterone nearly triple, and even normal men treated with testosterone saw their free levels roughly double.²⁸ At the same time, SHBG fell significantly in the testosterone-treated groups, amplifying the rise in free testosterone. The drop in SHBG makes physiological sense: androgens suppress SHBG production, so adding exogenous testosterone lowers the very protein that would otherwise bind it, creating a double effect on the free fraction.

This dynamic matters for dose monitoring. If a clinician tracks only total testosterone during replacement therapy, they may underestimate how much free testosterone the patient is actually getting, because the simultaneous SHBG suppression means a larger share of each testosterone molecule ends up unbound. Monitoring both total testosterone and SHBG (or calculated free testosterone) gives a clearer picture of whether the dose is appropriate, too low, or pushing free levels unnecessarily high.

Acute Illness and Temporary Drops

Free testosterone can fall sharply during serious illness. Critical illness suppresses the entire hypothalamic-pituitary-gonadal axis, and SHBG often rises during acute inflammatory states, further squeezing the free fraction. A meta-analysis of studies in COVID-19 patients found lower free testosterone levels compared to healthy controls, alongside increased SHBG.²⁹ This pattern is not unique to COVID; it is a well-known feature of critical illness across many conditions.

The practical message is to avoid making permanent diagnostic decisions based on testosterone levels drawn during or immediately after a major illness. A low free testosterone in the ICU or in the weeks after a severe infection is expected physiology, not necessarily a signal of chronic deficiency. Repeating the test after full recovery gives a much more reliable picture of baseline hormonal status.